Phase III
Ended Definitive Contract Awarded Last action
- Contract number
- W81XWH15C0140
- Awardee
-
Emergent Travel Health Inc. UEI CXEUFMM1FXY8
- Awarding agency
-
Medical Command
Department of the Army, Department of Defense
- Obligated
- $111,370
Award facts
- Contract value 100% obligated
- $111,369.51 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 541712 Research and Development in the Physical, Engineering, and Life Sciences (except Biotechnology)
- Set-aside
- No set-aside
- Competition
- Not Competed · 1 offer Only One Source
- Pricing
- Other
- Place of performance
- Redwood City, CA 94063, USA
- Research
- SBIR Program Phase III Action
Award details come from SAM.gov/FPDS.
About this award
This is a Definitive Contract awarded by the U.S. Army Medical Command (MEDCOM) to Emergent Travel Health Inc., a for-profit biopharmaceutical company, for $111,369.51. The contract is for Phase III of a Small Business Innovation Research (SBIR) program action, with an ultimate completion date of April 27, 2016. Emergent Travel Health Inc. has previously provided vaccine stability testing, vaccine development, and vaccine procurement services to federal agencies including the National Institutes of Health and the Department of Justice. This contract does not have a set-aside designation.
Quick answers
Who was awarded contract W81XWH15C0140?
W81XWH15C0140 was awarded to Emergent Travel Health Inc. by Medical Command (Department of the Army) on September 28, 2015.
How much is contract W81XWH15C0140 worth?
The government has obligated $111,370 on W81XWH15C0140.
Was contract W81XWH15C0140 competed?
The extent of competition for W81XWH15C0140 was not competed. The government received 1 offer.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award